| Literature DB >> 33884666 |
Ye Tu1,2, Ran Yang1,3, Xin Xu1,2, Xuedong Zhou1,2.
Abstract
The gastrointestinal tract is colonized by trillions of microorganisms, consisting of bacteria, fungi, and viruses, known as the "second gene pool" of the human body. In recent years, the microbiota-gut-bone axis has attracted increasing attention in the field of skeletal health/disorders. The involvement of gut microbial dysbiosis in multiple bone disorders has been recognized. The gut microbiota regulates skeletal homeostasis through its effects on host metabolism, immune function, and hormonal secretion. Owing to the essential role of the gut microbiota in skeletal homeostasis, novel gut microbiota-targeting therapeutics, such as probiotics and prebiotics, have been proven effective in preventing bone loss. However, more well-controlled clinical trials are still needed to evaluate the long-term efficacy and safety of these ecologic modulators in the treatment of bone disorders. ©2021 Society for Leukocyte Biology.Entities:
Keywords: bone metabolism; gut microbiota; osteoimmunology; osteoporosis; probiotics
Year: 2021 PMID: 33884666 DOI: 10.1002/JLB.3MR0321-755R
Source DB: PubMed Journal: J Leukoc Biol ISSN: 0741-5400 Impact factor: 4.962